tirzepatide and perimenopause Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Understanding the Impact of Tirzepatide

A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily licensed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities

Semaglutide may indirectly affect the absorption and effectiveness of warfarin by changing how nutrients and medications move through the digestive system

IGF-1 LR3 1mg Summary Description: IGF1-LR3 (Long R3 Insulin-like Growth Factor 1) is a recombinant peptide analog of human IGF-1 designed for enhanced bioavailability and potency

These insights emphasize the need for policy changes to improve insurance coverage for individuals without type 2 diabetes, as well as strategies to manage side effects and enhance patient adherence, Ezekiel Emanuel, MD, PhD, vice provost for Global Initiatives and co-director of the Healthcare Transformation Institute, University of Pennsylvania, told Healio

vanGraafA.A